Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)

K. de Wit, J.J. Schaapman, F. Nevens, J. Verbeek, S. Coenen, F.J.C. Cuperus, M. Kramer, E.T.T.L. Tjwa, N. Mostafavi, M.G.W. Dijkgraaf, O.M. van Delden, U.H.W. Beuers, M.J. Coenraad, R.B. Takkenberg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number000531
Number of pages8
JournalBMJ Open Gastroenterology
Volume7
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • ascites
  • european association
  • hepatic encephalopathy
  • liver cirrhosis
  • management
  • portal hypertension
  • portal-hypertension
  • risk
  • MANAGEMENT
  • ASCITES
  • RISK
  • EUROPEAN ASSOCIATION
  • PORTAL-HYPERTENSION

Cite this